期刊文献+

包膜综合处理及假体置换联合大分子透明质酸注射治疗隆乳术后包膜挛缩

Comprehensive Capsular Treatment and Prosthesis Replacement Combined with Macromolecular Hyaluronic Acid Injection to Treat Capsular Contracture after Breast Augmentation
下载PDF
导出
摘要 目的:探讨包膜综合处理及假体置换联合大分子透明质酸注射治疗隆乳术后包膜挛缩的效果。方法:选择2014年5月-2021年4月笔者医院收治的29例假体隆乳后包膜挛缩患者为研究对象,患者年龄21~53岁,初次假体隆乳后1~6年,平均2.3年,其中Baker分级Ⅲ级21例,Ⅳ级8例,单侧3例,双侧26例。采用乳晕切口,完全去除乳房增厚包膜11例,包膜松解18例,均置换假体。在隆乳术后即刻或术后48 h内,每侧注入大分子透明质酸10~20 ml,用于预防包膜再次挛缩。结果:29例患者术后即刻均获得满意外形,随访1~5年,乳房外形保持良好,柔软度好,无乳房疼痛、硬块和乳头感觉缺失,Baker分级Ⅰ级22例,Ⅱ级7例,无假体破裂、乳房下垂及上移等并发症。结论:包膜综合处理及假体置换联合大分子透明质酸注射治疗隆乳术后包膜挛缩疗效好,且能有效降低乳房包膜再次挛缩的概率。 Objective To investigate the effect of comprehensive capsular treatment and prosthesis replacement combined with macromolecular hyaluronic acid injection in the treatment of capsular contracture after breast augmentation.Methods From May 2014 to April 2021,29 patients with capsular contracture after breast augmentation in the author's hospital were selected as the research objects,aged 21-53 years,1-6 years after the first breast augmentation,with an average of 2.3 years.There were 21 cases of Baker gradeⅢ,8 cases of gradeⅣ,3 cases of unilateral and 26 cases of bilateral.Using areola incision,the thickened breast capsule was completely removed in 11 cases,and the capsule was released in 18 cases,and all of them were replaced with prostheses.Macromolecule hyaluronic acid 10-20 ml was injected into each side immediately or within 48 hours after breast augmentation to prevent capsular contracture again.Results All patients were followed up for 1 to 5 years,the breast shape and softness were good,and there was no breast pain,hard mass and loss of nipple sensation.There were 22 cases of Baker gradeⅠand 7 cases of Baker gradeⅡ.Conclusion Comprehensive capsular treatment and prosthesis replacement combined with macromolecular hyaluronic acid injection are effective in the treatment of capsular contracture after breast augmentation,and can effectively reduce the probability of capsular contracture again.
作者 朱小平 方柏荣 ZHU Xiaoping;FANG Bairong(Department of Plastic Surgery,the Second Xiangya Hospital,Central South University,Changsha 410011,Hunan,China;Changsha Pengai Medical Aesthetic Hospital,Changsha 410011,Hunan,China)
出处 《中国美容医学》 CAS 2024年第8期30-33,共4页 Chinese Journal of Aesthetic Medicine
关键词 大分子透明质酸 隆乳 包膜挛缩 假体置换 复发 macromolecular cross-linked hyaluronic acid breast augmentation capsular contracture prosthetic replacement relapse
  • 相关文献

参考文献2

二级参考文献41

  • 1杨维琦,杨佩瑛,范金财,栾杰,张旭辉,朱志祥.硅凝胶乳房假体包膜组织学研究[J].中华医学美学美容杂志,2004,10(4):222-225. 被引量:13
  • 2薛红宇,陈育哲,李东,尤维涛,李比.包膜囊上再置乳房假体隆乳术[J].中华医学美学美容杂志,2005,11(1):11-13. 被引量:2
  • 3曹建平,方彰林,丁芷林,王积恩.隆乳术后纤维包膜挛缩乳房硬化30例讨论[J].医学美学与美容学杂志,1994,1(1):20-21. 被引量:1
  • 4郭树忠.乳房整形美容手术进展[J].中国美容医学,2005,14(4):409-412. 被引量:9
  • 5Eyden B.Electron microscopy in the study of myofibroblastic lesions.Semin Diagn Pathol 2003;20(1):13-24
  • 6Ehrlich HP,Desmouliere A,Diegelmann RF,et al.Morphological and immunochemical differences between keloid and hypertrophic scar.Am J Pathol 1994;145(1):105-113
  • 7Gabbiani G.The cellular derivation and the life span of the myofibroblast.Pathol Res Pract 1996;192(7):708-711
  • 8Darby I,Skalli O,Gabbiani G.Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing.Lab Invest 1990;63(1):21-29
  • 9Serini G,Gabbiani G.Mechanisms of myofibroblast activity and phenotypic modulation.Exp Cell Res 1999;250(2):273-283
  • 10Linares HA.From wound to scar.Burns 1996;22(5):339-352

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部